Physician profile
Rose Guo
NPI 1396199543
$617.80
in general payments reported to CMS, 2019-2025
13 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Clinical Genetics (M.D.) provider received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $49.96 · 2024: $223 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $169.99 | 2025 | |
| Insulet Corporation | $78.52 | 2024-2025 | Omnipod |
| Rhythm Pharmaceuticals, INC. | $74.91 | 2023-2024 | Imcivree, Imcivree |
| Kyowa Kirin, INC. | $52.45 | 2024 | Crysvita |
| Acadia Pharmaceuticals INC | $43.90 | 2025 | Daybue |
| Ultragenyx Pharmaceutical INC. | $30.28 | 2024 | Dojolvi |
| Sequel Med Tech, LLC | $27.59 | 2025 | Twiist |
| Biomarin Pharmaceutical INC. | $27.02 | 2024 | Brineura |
| Chiesi USA, INC. | $24.85 | 2024 | Elfabrio |
| Tolmar, INC. | $23.50 | 2024 | |
| Soleno Therapeutics, INC. | $23.37 | 2025 | Vykat Xr |
| Tandem Diabetes Care, INC. | $21.76 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $19.66 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.